Lumida
/BTMD
⌘K
Biote Corp

Biote Corp

BTMD
$2.43USD+2.10%+0.05 today

MARKET CAP

91.3M

P/E (TTM)

4.7x

FWD P/E

8.4x

DAY RANGE

$2 – $3

52W RANGE

$1
$5

AI Summary

Stalk
StalkMedium

BTMD has transitioned into a confirmed Stage 2 advance after breaking above multi-month resistance, but with price extended above rising EMAs and 50 DMA into extreme overbought, we will wait for a constructive pullback into the 9 EMA, 21 EMA, and 50 DMA support zone before adding exposure, consistent with our Free Cash Flow + Buybacks strategy and mindful that failure to hold these levels would undermine the medium-term bullish structure.

  • FY26 revenue guidance above $190M indicates procedural recovery post-recall
  • Dietary supplement revenue up 30% YoY to $11M, driven by e-commerce
  • Q1 revenue fell 8.3% YoY to $44.9M, with procedure rev down 13.2%
Full analysis →
Insider Trades3 trades
DateSideTickerInsiderRoleSharesPriceMkt Cap52W High52W LowValue% ChgRuleAI View
Mar 17, 2025BuyBTMDBret ChristensenChief Executive Officer37,595$3.87$91.3M-48.84%+91.34%$145.5KStalk
Sep 9, 2024SellBTMDRobert Charles PetersonChief Financial Officer32,874$6.20$91.3M-48.84%+91.34%$203.8K-100.00%Stalk
Jul 9, 2024SellBTMDRobert Charles PetersonChief Financial Officer11,376$7.57$91.3M-48.84%+91.34%$86.1K-25.71%Stalk